Semaglutide, Tirzepatide, Retatrutide, and Beyond While all GLP-1RAs share core mechanisms, important differences exist between these medications: Semaglutide (Ozempic, Wegovy) features weekly dosing and has demonstrated substantial weight loss effects (approximately 15% body weight reduction)
References Godlewska BR, Williams S, Emir UE, Chen C, Sharpley AL, Goncalves AJ, et al
Keep a bag of frozen spinach on hand for instant nutrients with no prep
These sources may market retatrutide alongside FDA-approved compounds like semaglutide and tirzepatide, sometimes implying a level of pharmaceutical oversight that does not actually exist for retatrutide as an investigational compound